Effect of Nimotuzumab Combined with Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Na He

2013-01-01

Abstract:Objective To investigate the safety and efficacy of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma.Methods Forty untreated cases of III-Ⅳa stage nasopharyngeal undifferentiated non-keratinizing carcinoma were divided into two groups according to their first visit date,20 cases in each group.The treatment group was given nimotuzumab(intravenous infusion of 100mg once a week),and the treatment lasted for 6-8 weeks;Conformal intensity modulated radiotherapy combined with concurrent CF chemotherapy was performed in the treatment group for 2 to 6 cycles.Conformal intensity modulated radiotherapy combined with CF chemotherapy was performed in the control group,the same as in the treatment group.Immunohistochemistry was used to detect epidermal growth factor receptor(EGFR) in tumor tissues while in situ hybridization assay was used to detect EBER expression.The safety and efficacy of treatment were evaluated 3,6 and 12 months after treatment,respectively.Results The positive rates of EGFR expression in the treatment group and control group were 90.0% and 100.0%,respectively.The positive rate of EBER expression was 100.0% in the two groups.There was no significant difference in the positive rates of EGFR and EBER expression between two groups(P 0.05).The efficacy of treatment for treatment group was superior to that for control group 3 months after treatment as well as 6 months after treatment(P 0.05);There was no significant difference in the severity of adverse reaction between two groups during treatment period(P 0.05).Conclusion The positive rate of EGFR expression in the nasopharyngeal undifferentiated non-keratinizing carcinoma is high.Nimotuzumab combined with concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma can improve the efficacy,its adverse reactions are similar with those of concurrent chemoradiotherapy,and patient tolerance is good.